Details for New Drug Application (NDA): 217542
✉ Email this page to a colleague
NDA 217542 describes BARICITINIB, which is a drug marketed by Aurobindo Pharma Ltd and is included in one NDA. Additional details are available on the BARICITINIB profile page.
The generic ingredient in BARICITINIB is baricitinib. One supplier is listed for this compound. Additional details are available on the baricitinib profile page.
The generic ingredient in BARICITINIB is baricitinib. One supplier is listed for this compound. Additional details are available on the baricitinib profile page.
Summary for 217542
| Tradename: | BARICITINIB |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | baricitinib |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Jul 22, 2024 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Jul 22, 2024 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
